Author + information
- Received March 10, 1997
- Revision received October 3, 1997
- Accepted November 26, 1997
- Published online March 1, 1998.
- Kenneth M Shaffer, MDA,
- Charles E Mullins, MD, FACCA,*,
- Ronald G Grifka, MDA,
- Martin P O’Laughlin, MD, FACCA,
- William McMahon, MDA,
- Frank F Ing, MDA and
- Michael R Nihill, MD, FACCA
- ↵*Dr. Charles E. Mullins, Division of Pediatric Cardiology, MC 2-2531, Texas Children’s Hospital, 6621 Fannin, Houston, Texas 77030.
Objectives. This report describes the results of the Food and Drug Administration’s phase 1 and 2 clinical trials of intravascular stents at Texas Children’s Hospital.
Background. Since the late 1980s, intravascular stent implantation for the treatment of arterial and venous stenoses in congenital heart disease has been highly successful.
Methods. Stents were placed in postoperative pulmonary artery (PA) stenoses, congenital PA stenoses or stenoses of systemic veins/venous anastomoses. Prospective collection of data according to protocol was done before intervention, after stent implantation and at follow-up catheterization.
Results. At stent implantation, pressure gradients decreased significantly in all three groups (mean ± SD): from 46 ± 25 to 10 ± 13 mm Hg in postoperative PA stenoses (p < 0.001); from 71 ± 45 to 15 ± 21 mm Hg in congenital PA stenoses (p < 0.001); and from 7 ± 6 to 1 ± 2 mm Hg in stenoses of systemic veins/venous anastomoses stenoses (p < 0.001). Vessel diameters markedly increased: from 6 ± 3 to 12 ± 3 mm in postoperative PA stenoses (p < 0.001); from 3 ± 1 to 9 ± 1 mm in congenital PA stenoses (p < 0.001); and from 3 ± 4 to 12 ± 4 mm in stenoses of systemic veins/venous anastomoses (p < 0.001). In the postoperative and congenital PA stenoses groups, right ventricular pressure decreased (right ventricular pressure indexed to femoral artery pressure ratio): from 0.63 ± 0.2 to 0.41 ± 0.02 (p < 0.001) and from 0.71 ± 0.3 to 0.55 ± 0.35 (p = 0.04), respectively. Perfusion to a single affected lung increased from 31 ± 17% to 46 ± 14% (p < 0.001). On recatheterization (mean 14 months), results varied minimally. Repeat angioplasty of residual stent stenoses was safe and effective. Complications included four early patients with stent migration, three with stent thrombosis and two deaths. There were no late complications. Significant restenosis occurred in only three patients.
Conclusions. Intravascular stents for the treatment of vascular stenoses in congenital heart disease provide excellent immediate and long-term results.
☆ To discuss this article on-line, visit the ACC Home Page at www.acc.org/membersand click on the JACC Forum
☆☆ This study was completed using financial support for administrative and data processing services provided by Baylor College of Medicine/Texas Children’s Hospital research funds.
- Received March 10, 1997.
- Revision received October 3, 1997.
- Accepted November 26, 1997.
- The American College of Cardiology